ONEBIO LABS / RESEARCH INFORMATION
CJC-1295 DAC
Research Peptide | GHRH Analogue
Technical specifications
| Classification | Long-acting growth-hormone-releasing hormone analogue |
|---|---|
| Molecular formula | C165H269N47O46 |
| Molecular weight | 3647.2 g/mol |
| CAS | 446262-90-4 |
| PubChem CID | 91971820 |
| Form | Lyophilised peptide |
| Purity / testing | Refer to product-specific batch COA / analytical documentation |
| Intended use | Laboratory and research purposes only |
CJC-1295 DAC and non-DAC forms are distinct research materials and should not share technical identifiers without batch confirmation.
01 / PRODUCT INFORMATION
Product description
CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH). The DAC form incorporates a reactive group designed to extend persistence through albumin binding and has been studied for its effects on growth-hormone and IGF-1 signalling.
02 / RESEARCH CONTEXT
Research overview
Research areas: GHRH receptor signalling; growth-hormone secretion; IGF-1 response; endocrine pharmacology.
03 / PRODUCT INFORMATION
ONE BIOLABS quality
ONE BIOLABS provides research products with product information and available batch documentation where applicable. Batch-specific identity, purity, concentration, salt form, testing and manufacturing claims should be stated only where supported by the applicable Certificate of Analysis or other analytical documentation.
04 / STORAGE
Refrigerate at 2–8°C
Unless the product-specific label or Certificate of Analysis states otherwise, store refrigerated at 2–8°C, protected from direct light, excessive heat and moisture. Keep the container securely closed. Product-specific storage instructions and stability data should take precedence.
Important notice
FOR RESEARCH PURPOSES ONLY. This product information is intended for laboratory and research reference. Products described in this document are not intended for human consumption, self-administration, diagnosis, treatment, prevention or cure of disease unless supplied as an appropriately authorised medicinal product through lawful channels. No dosage, administration or therapeutic guidance is provided.
Research findings, especially preclinical findings, should not be interpreted as proof of human safety or efficacy.
Reviews
There are no reviews yet.